Abrams Eye Center

Cleveland, Ohio 44115

0 studies enrolling now · 23 studies all time

What they study most

Bacterial Conjunctivitis, Blepharitis, Blepharoptosis, Dry Eye, Dry Eye Disease, Dry Eye Syndromes, Elevated Intraocular Pressure, Glaucoma, Glaucoma and Ocular Hypertension, Kerato Conjunctivitis Sicca, Keratoconjunctivitis Sicca, Ocular Hypertension

Studies at this site

• A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease — Completed
• Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease — Completed
• Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye — Completed
• Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma — Completed
• DE-117 Spectrum 5 Study — Completed
• A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study — Completed
• Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma — Completed
• Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) — Completed
• Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED) — Completed
• Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure — Status unconfirmed
• A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3) — Completed
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease — Completed
• Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease — Completed
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease — Completed
• Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis — Completed
• Study of Safety of RVL-1201 in Treatment of Blepharoptosis — Completed
• Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6 — Completed
• Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome — Completed
• To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca — Completed
• AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure — Completed
• Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Vehicle for Bacterial Conjunctivitis (C-01-401-003) — Completed
• A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease — Completed
• The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period — Completed